SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-117212
Filing Date
2023-11-13
Accepted
2023-11-13 16:11:28
Documents
14
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2330513d2_8k.htm   iXBRL 8-K 25963
2 EXHIBIT 99.1 tm2330513d2_ex99-1.htm EX-99.1 79608
6 GRAPHIC tm2330513d2_ex99-1img001.jpg GRAPHIC 7443
  Complete submission text file 0001104659-23-117212.txt   301572

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cara-20231113.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20231113_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20231113_pre.xml EX-101.PRE 22375
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2330513d2_8k_htm.xml XML 3423
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 231398804
SIC: 2834 Pharmaceutical Preparations